Lataa...
Androgen deprivation and immunotherapy for the treatment of prostate cancer
Prostate cancer is the most common newly diagnosed malignancy in men, and the second most common cause of cancer-related death in the United States. The primary treatment for recurrent prostate cancer is androgen deprivation, and this therapy is typically continued life-long for patients with metast...
Tallennettuna:
| Julkaisussa: | Endocr Relat Cancer |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669826/ https://ncbi.nlm.nih.gov/pubmed/28814451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0145 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|